-
Mashup Score: 4
An abstract is unavailable.
Source: journals.lww.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4
An abstract is unavailable.
Source: journals.lww.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4
An abstract is unavailable.
Source: journals.lww.comCategories: General Medicine News, Onc News and JournalsTweet
Olutasidenib, a small molecule oral inhibitor targeting mutated-IDH1 (mIDH1), has gained attention as a promising therapy for relapsed/refractory acute myeloid #leukemia. Keep reading: https://t.co/177z5Upklu #AML #CancerResearch https://t.co/MqgH7c8NTp